He just finished a 10 day course of levaquin for pneumonia.
BCxs were drawn and he received Vanc and Zosyn for presumed pneumonia.
He was placed on BiPap 13/8 with ABG of 7.49/34/326.
He was briefly hypotensive to SBP of 70s, responded to IVF bolus.
CXR showed Patient was started on heparin gtt and he was given azithromycin.
Past Medical History: -Squamous cell of the tongue, stage IV, metastatic to the zygomatic arch and skull -Latent TB   Social History: Unable to obtain  Family History: No significant history  Physical Exam: Vitals: T: BP: P: R: 18 O2: General: Alert, oriented to self, [**Hospital3 **], [**2111-3-2**], no acute distress, extremely cachetic, dysarthric HEENT: Sclera anicteric, MM dry, yellow exudate over upper palate and base of tongue Neck: supple, JVP not elevated, no LAD Lungs: Coarse LLL crackles, no wheezes CV: Regular rate and rhythm, no murmurs Abdomen: normoactive bowel sounds, soft, tender in LLQ, no rebound or guarding GU: Foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema   Pertinent Results: Admission labs: [**2111-3-13**] 07:21PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.013 [**2111-3-13**] 07:21PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-SM [**2111-3-13**] 07:21PM URINE  RBC-1 WBC-8* BACTERIA-NONE YEAST-NONE EPI-<1 [**2111-3-13**] 07:21PM URINE  AMORPH-RARE [**2111-3-13**] 07:21PM URINE  MUCOUS-RARE [**2111-3-13**] 07:21PM URINE  EOS-NEGATIVE [**2111-3-13**] 07:16PM   PTT-81.7* [**2111-3-13**] 09:00AM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.017 [**2111-3-13**] 09:00AM URINE  BLOOD-SM NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2111-3-13**] 09:00AM URINE  RBC-0-2 WBC-[**4-3**] BACTERIA-FEW YEAST-NONE EPI-<1 [**2111-3-13**] 09:00AM URINE  HYALINE-[**4-3**]* [**2111-3-13**] 09:00AM URINE  MUCOUS-FEW [**2111-3-13**] 08:38AM   COMMENTS-GREEN TOP [**2111-3-13**] 08:38AM   GLUCOSE-106* LACTATE-3.1* NA+-146 K+-4.4 [**2111-3-13**] 08:38AM   HGB-10.6* calcHCT-32 [**2111-3-13**] 08:30AM   GLUCOSE-109* UREA N-95* CREAT-2.0* SODIUM-145 POTASSIUM-4.7 CHLORIDE-107 TOTAL CO2-26 ANION GAP-17 [**2111-3-13**] 08:30AM   estGFR-Using this [**2111-3-13**] 08:30AM   ALT(SGPT)-14 AST(SGOT)-34 CK(CPK)-124 ALK PHOS-139* TOT BILI-0.3 [**2111-3-13**] 08:30AM   LIPASE-15 [**2111-3-13**] 08:30AM   cTropnT-0.10* [**2111-3-13**] 08:30AM   CK-MB-6 [**2111-3-13**] 08:30AM   ALBUMIN-3.3* CALCIUM-13.4* PHOSPHATE-3.8 MAGNESIUM-2.2 IRON-22* [**2111-3-13**] 08:30AM   calTIBC-192* VIT B12-795 FOLATE-GREATER TH FERRITIN-GREATER TH TRF-148* [**2111-3-13**] 08:30AM   WBC-4.6 RBC-3.64* HGB-10.9* HCT-34.8* MCV-96 MCH-30.0 MCHC-31.4 RDW-16.2* [**2111-3-13**] 08:30AM   WBC-4.6 RBC-3.64* HGB-10.9* HCT-34.8* MCV-96 MCH-30.0 MCHC-31.4 RDW-16.2* [**2111-3-13**] 08:30AM   NEUTS-49* BANDS-6* LYMPHS-29 MONOS-14* EOS-0 BASOS-0 ATYPS-0 METAS-1* MYELOS-1* [**2111-3-13**] 08:30AM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-NORMAL MACROCYT-1+ MICROCYT-NORMAL POLYCHROM-NORMAL [**2111-3-13**] 08:30AM   PLT SMR-NORMAL PLT COUNT-203 [**2111-3-13**] 08:30AM   PT-14.3* PTT-32.9 INR(PT)-1.2* .
LENIs: No DVT  [**2111-3-27**] 03:57AM BLOOD WBC-13.9* RBC-3.16*# Hgb-9.6*# Hct-28.9* MCV-92 MCH-30.6 MCHC-33.4 RDW-18.7* Plt Ct-207 [**2111-3-22**] 03:50AM BLOOD Neuts-88.9* Lymphs-6.8* Monos-3.2 Eos-0.8 Baso-0.2 [**2111-3-27**] 03:57AM BLOOD PT-13.4 PTT-36.6* INR(PT)-1.1 [**2111-3-27**] 03:57AM BLOOD Glucose-107* UreaN-19 Creat-0.7 Na-139 K-4.2 Cl-109* HCO3-23 AnGap-11 [**2111-3-23**] 05:00AM BLOOD ALT-8 AST-19 LD(LDH)-201 AlkPhos-120 TotBili-0.1 [**2111-3-27**] 03:57AM BLOOD Calcium-9.4 Phos-2.1* Mg-1.9 [**2111-3-23**] 05:00AM BLOOD PTH-17 [**2111-3-22**] 03:50AM BLOOD Cortsol-18.9 [**2111-3-23**] 05:00AM BLOOD PARATHYROID HORMONE RELATED PROTEIN-PND [**2111-3-23**] 05:00AM BLOOD VITAMIN D 25 HYDROXY-PND  [**2111-3-25**] STOOL CLOSTRIDIUM DIFFICILE NEGATIVE [**2111-3-24**] STOOL CLOSTRIDIUM DIFFICILE NEGATIVE [**2111-3-24**] SPUTUM ACID FAST SMEAR-NEGATIVE [**2111-3-23**] BLOOD CULTURE - PENDING [**2111-3-23**] BLOOD CULTURE -PENDING [**2111-3-23**] BLOOD CULTURE -PENDING [**2111-3-23**] URINE CULTURE-NO GROWTH [**2111-3-23**] SPUTUM ACID FAST SMEAR-NEGATIVE [**2111-3-22**] SPUTUM ACID FAST SMEAR-NEGATIVE [**2111-3-21**] BLOOD CULTURE -FINAL NEGATIVE [**2111-3-21**] BLOOD CULTURE -FINAL NEGATIVE [**2111-3-21**] URINE -FINAL NEGATIVE [**2111-3-14**] URINE Legionella NEGATIVE  CT NECK 1.
Patent airway with endotracheal tube in place.
Left cervical soft tissue thickening with adjacent fat stranding may represent post-surgical and radiation therapy change in this region.
Partial strap muscle resection and submental surgical clips evident on the left.
Partial visualization of a large right chest wall mass extending into right lung with multifocal osseous metastasis.
Partially visualized endotracheal tube, nasogastric tube, and left approach central venous catheter appear to be in expected locations.
Brief Hospital Course: Hospital course by problem:  Respiratory Failure secondary to difficulty protecting airway from oropharyngeal squamous cell carcinoma: Intially treated for pneumonia and ruled out for PE.
His respiratory status declined further after placement of a NG tube for oral vancomycin following a failed swallowing evaluation.
He was intubated for airway protection.
The possibility of tracheostomy and PEG was considered and the patient was seen by the ENT surgeon, but he elected to decline this intervention and to transistion to comfort-oriented care.
He was continued on IV flagyl.
PO vanco was added for increasing leukocytosis.
The infectious disease team recommended a 2 week course of IV flagyl and PO vancomycin.
He was transitioned to only IV flagyl to be completed on [**2111-4-7**] prior to discharge from the hospital because his NG tube was a source of discomfort.
Esophageal candidiasis: Noted during intubation in the ICU.
[**Month (only) 116**] have also contributed to profound leukocytosis.
Per ID team recommendations, treated with fluconazole, initially PO and then IV for a 2 week course from [**2111-3-23**].
His oral discomfort improved significantly while on this medication.
Once his NG tube was removed, he was transitioned to po clotrimazole troches on [**2111-3-30**] to complete an additonal 1 week course.
Pain management was initiated with lidocaine patches to hips, fentanyl patch, and po morphine concentrate.
Please uptitrate fentanyl patch (increased to 25mcg/hr on [**2111-3-29**]) and po morphine concentrate to acheive adequate pain control.
Hypercalcemia: S/p pamidronate x1 [**3-20**].
FEN: Dubhoff placed during inbutation to allow for gastric access and patient was transitioned from TPN to tube feeds.
Tube feeds were eventually stopped due to exacerbation of diarrhea.
The patient elected to keep the dubhoff tube in place to continue receiving PO vancomycin and other medications until the day of discharge from the hospital when it was removed for ongoing discomfort.
Goals of Care: After multiple discussion with palliative care and the ENT surgeon regarding option of tracheostomy the patient elected to change his code status from full to DNR/DNI, with focus on comfort.
Medications on Admission: Morphine Flagyl Stool softeners  Discharge Medications: 1.
Fluticasone 50 mcg/Actuation Spray, Suspension Sig: Two (2) Spray Nasal DAILY (Daily).
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1) neb Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing.
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal HS (at bedtime) as needed for constipation.
Scopolamine Base 1.5 mg Patch 72 hr Sig: One (1) Patch 72 hr Transdermal Q3 DAYS PRN () as needed for Secretions.
Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One (1) Adhesive Patch, Medicated Topical DAILY (Daily).
Heparin Flush (10 units/ml) 2 mL IV PRN line flush PICC, heparin dependent: Flush with 10mL Normal Saline followed by Heparin as above daily and PRN per lumen.
Metronidazole in NaCl (Iso-os) 500 mg/100 mL Piggyback Sig: One (1) bag Intravenous Q8H (every 8 hours) for 8 days: Last day [**2111-4-7**].
Fentanyl 25 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr Transdermal Q72H (every 72 hours) as needed for onc pain: Titrate dose up prn.
Morphine Concentrate 20 mg/mL Solution Sig: 5-20 mg PO Q1H (every hour) as needed for pain, shortness of breath: may up titrate as necessary for pain control.
Clotrimazole 10 mg Troche Sig: One (1) Troche Mucous membrane QID (4 times a day) for 7 days: may discontinue if unable to tolerate.
Discharge Disposition: Extended Care  Facility: Roscommon  Discharge Diagnosis: Primary: respiratory failure, clostridium difficile colitis, metastatic squamous cell carcinoma, positive PPD   Discharge Condition: Patient is alert and oriented, bed bound at baseline, hemodynamically stable with waxing and [**Doctor Last Name 688**] oxygen requirements.
You were ruled out for active tuberculosis and did require a breathing tube as we sorted out whether any further treatment for your cancer was possible.
After discussing with you that no further treatment was available for your cancer, the breathing tube was removed and your care was transitioned to hospice care with a goal of treating any breathing difficulty with oxygen, good oral care, and pain medications.
